Dr. Juurlink on prescribing medical marijuana

November 7, 2014 Facebook Twitter LinkedIn Google+ Videos

In a new Canadian Medical Association Journal (CMAJ) article, Dr. David Juurlink, head of Sunnybrook’s division of clinical pharmacology and toxicology, makes a case for judicious prescribing of cannabis to patients who report meaningful benefit from it.

Read more on Sunnybrook Hospital

Read Dr. David Juurlink’s article on CMAJ